USI Payroll Find Us On Facebook  Find Us On Facebook
Payroll & HR Packages »
Request for Proposal »
Contact Us »
You did not go into business to be a human resource professional. Fortunately for you, we did!

Strovis recognizes Cory Stephens as Football Team Character Counts Recipient

December 11, 2019 at 1:48 pm

Pictured Left to Right: Mark Nash, GHS Booster Club; Tony Jordan, Strovis Holdings President; Corey Stephens, Award Recipient; Brian Coleman, Head Football Coach

Cory Stephens was honored as the Georgetown High School Football Team Strovis Character Counts Award Recipient during the team’s annual banquet held December 5, 2019 in Georgetown, SC.   Cory is the son of Monica Garrett and Cory Stephens and is a senior at Georgetown High. The Football team coach, Brian Coleman, commented stating “Cory is a student athlete that is committed to both academics and athletics. He has a full school class schedule of college level courses and continues to give a winning commitment to his football team. He has nearly perfect attendance in the after school weight lifting program while maintaining impressive grades. He has overcome many injuries in the last 2 years playing football but he never gives up.”  Coach Coleman also stated that even though he had a close family member pass away in Miami, he scheduled his travel for the services around his football schedule.

The award was presented by Tony Jordan, President of Strovis Holdings and Mark Nash representing the GHS Booster club. The Strovis Character Counts program honors student-athletes who excel in their chosen sport, as well as in life. Students who hold strong character traits are selected for the award. They are nominated by members of the coaching staff. Cory was specifically recognized for showing the character traits of dependability and determination.

Strovis partnered with the Georgetown High School Bulldogs Athletic Booster Club to create the awards program in the fall of 2017. The Booster Club remains a co-sponsor for the 2018-2019 school year.

Founded in Georgetown in 1998, Strovis Holdings oversees three divisions of the company: Strovis Payroll & HR, Strovis Benefits and Strovis Insurance. The company serves clients in 32 states from South Carolina.

Categories: Compliment Character Award.

Generic Drug Makers Sued over Pricing Practices

December 10, 2019 at 6:14 pm

generic drug pricing

One of the country’s largest health insurers has sued a number of pharmaceutical companies, accusing them of running a price-fixing cartel of common generic drugs.

Humana Inc. has accused the companies of colluding on the prices of generics to the detriment of health insurers that have to pay for these drugs. Humana said in its lawsuit that this collusion prevented fair competition among insurers that could have reduced the cost of many of these drugs.

The background

The lawsuit comes after 45 states signed on to a suit last year over an alleged scheme among generic drug manufacturers to fix the price of some 300 medications. The states are seeking unspecified damages for what they say they had to overpay for drugs for Medicaid patients as a result of the alleged cartel.

Humana accused Teva Pharmaceuticals, the largest generic drug producer in the world, of being the ringleader of the alleged scheme, which fixed, increased or maintained the prices of more than 100 generic drugs.

“They leveraged the culture of cronyism in the generic drug industry to avoid price erosion, increase prices for targeted products, and maintain artificially inflated prices across their respective product portfolios without triggering a ‘fight to the bottom’ among competitors,” Humana wrote in the complaint, which it lodged with the U.S. District Court for the Eastern District of Pennsylvania.

The lawsuit adds to the troubles faced by generic drug companies. Earlier in 2019, a number of states joined to sue drug makers, including Teva Pharmaceuticals. The suit also named multiple executives from Teva and other generic manufacturers as individual defendants.

An investigation by multiple states led by Connecticut accused generic drug makers of “illegal collusion,” refuting arguments by the manufacturers that price increases were caused by industry consolidation and Food and Drug Administration-mandated plant closures.

Humana says the drug companies conspired to set market shares and customers for each company, and that they also agreed not to compete with each other for those customers so that each company could maintain or raise the price of its generic pharmaceuticals.

This is the second lawsuit Humana has filed against generic pharmaceutical companies. It filed a similar case in August 2018 against a handful of drug makers, accusing them of price fixing. That case listed far fewer drugs than the latest salvo.

Lawsuit highlights industry chasing profits

The generics industry used to be highly competitive, but over the years, things changed and suddenly allegedly “coordinated price hikes on identical generic drugs became almost routine,” the Washington Post wrote in an article last year that covered the alleged scheme and lawsuit by states.

While generics account for 90% of the prescriptions written, they only account for 23% of the total drug spend in the country, according to the Association for Accessible Medicines. Despite that, there has been a noticeable and inexplicable uptick in the price of drugs in recent years, sparking outrage among consumers, health insurers and states that run their own Medicaid programs.

If the allegations are true, the parties affected run the gamut from consumers ? who have high copays or high deductibles for their pharmaceuticals ? to hospitals and insurance companies.

Categories: Uncategorized.

Tags: , ,